184 related articles for article (PubMed ID: 18766999)
21. [Demonstration of low-energy quantum emitters by means of whole-body counters at the State Board of Nuclear Safety and Radiation Protection].
Lössner V
Radiobiol Radiother (Berl); 1977; 18(4):397-440. PubMed ID: 414297
[No Abstract] [Full Text] [Related]
22. Beta induced Bremsstrahlung exposure in DNA and RNA.
Manjunatha HC; Rudraswamy B
Phys Med; 2011 Oct; 27(4):188-93. PubMed ID: 21216170
[TBL] [Abstract][Full Text] [Related]
23. Complexes of low energy beta emitters 47Sc and 177Lu with zoledronic acid for bone pain therapy.
Majkowska A; Neves M; Antunes I; Bilewicz A
Appl Radiat Isot; 2009 Jan; 67(1):11-3. PubMed ID: 18929490
[TBL] [Abstract][Full Text] [Related]
24. Beta decay in science and medicine.
Welsh JS
Am J Clin Oncol; 2007 Aug; 30(4):437-9. PubMed ID: 17762446
[TBL] [Abstract][Full Text] [Related]
25. Biokinetic and dosimetric modelling in the estimation of radiation risks from internal emitters.
Harrison J
J Radiol Prot; 2009 Jun; 29(2A):A81-A105. PubMed ID: 19454809
[TBL] [Abstract][Full Text] [Related]
26. Safe handling of tissue containing radioactive substances.
Warren S
Ann Clin Lab Sci; 1976; 6(3):207-8. PubMed ID: 942179
[TBL] [Abstract][Full Text] [Related]
27. Skin dose saving of the staff in 90Y/177Lu peptide receptor radionuclide therapy with the automatic dose dispenser.
Fioroni F; Grassi E; Giorgia C; Sara R; Piccagli V; Filice A; Mostacci D; Versari A; Iori M
Nucl Med Commun; 2016 Oct; 37(10):1046-52. PubMed ID: 27218429
[TBL] [Abstract][Full Text] [Related]
28. OPTIMAL BETA-RAY SHIELDING THICKNESSES FOR DIFFERENT THERAPEUTIC RADIONUCLIDES AND SHIELDING MATERIALS.
Cho YI; Kim JM; Kim JH
Radiat Prot Dosimetry; 2017 Apr; 174(1):13-20. PubMed ID: 27056144
[TBL] [Abstract][Full Text] [Related]
29. Detection of bremsstrahlung radiation of 90Sr-90Y for emergency lung counting.
Ho A; Hakmana Witharana SS; Jonkmans G; Li L; Surette RA; Dubeau J; Dai X
Radiat Prot Dosimetry; 2012 Sep; 151(3):443-9. PubMed ID: 22434925
[TBL] [Abstract][Full Text] [Related]
30. Use of the Oak Ridge National Laboratory tungsten-188/rhenium-188 generator for preparation of the rhenium-188 HDD/lipiodol complex for trans-arterial liver cancer therapy.
Jeong JM; Knapp FF
Semin Nucl Med; 2008 Mar; 38(2):S19-29. PubMed ID: 18243839
[TBL] [Abstract][Full Text] [Related]
31. Radiation protection to the eye and thyroid during diagnostic cerebral angiography: a phantom study.
Shortt CP; Malone L; Thornton J; Brennan P; Lee MJ
J Med Imaging Radiat Oncol; 2008 Aug; 52(4):365-9. PubMed ID: 18811760
[TBL] [Abstract][Full Text] [Related]
32. Radiolabeled microorganisms: comparison of different radioisotopic labels.
Kishore R
Rev Infect Dis; 1981; 3(6):1179-85. PubMed ID: 7342282
[TBL] [Abstract][Full Text] [Related]
33. Therapeutic Radiometals Beyond
Müller C; van der Meulen NP; Benešová M; Schibli R
J Nucl Med; 2017 Sep; 58(Suppl 2):91S-96S. PubMed ID: 28864619
[TBL] [Abstract][Full Text] [Related]
34. Dose assessment of bremsstrahlung induced by beta-emitting radioisotopes of uranium-238 series and lead in human tissues.
Manjunatha HC
Isotopes Environ Health Stud; 2014; 50(4):555-64. PubMed ID: 25348813
[TBL] [Abstract][Full Text] [Related]
35. Safe use of radioisotopes.
Meisenhelder J; Semba K
Curr Protoc Microbiol; 2006 Jun; Chapter 1():Unit1A.4. PubMed ID: 18770572
[TBL] [Abstract][Full Text] [Related]
36. Theoretical data of external Bremsstrahlung radiation cross-section of bone.
Manjunatha HC; Rudraswamy B
Appl Radiat Isot; 2007 Apr; 65(4):397-400. PubMed ID: 17113303
[TBL] [Abstract][Full Text] [Related]
37. The effects of a custom-made lead collar on dose rates of patients treated with 131I.
Stapel AG; van der Zant FM; Gommans GM; Boer RO; Reigman HI
Health Phys; 2009 May; 96(5 Suppl 2):S64-8. PubMed ID: 19359844
[TBL] [Abstract][Full Text] [Related]
38. Activity measurements of the high-energy pure beta-emitters 89Sr and 90Y by the TDCR efficiency calculation technique.
Simpson BR; Van Wyngaardt WM
Appl Radiat Isot; 2006; 64(10-11):1481-4. PubMed ID: 16584886
[TBL] [Abstract][Full Text] [Related]
39. Measurement of depth distributions of (3)H and (14)C induced in concrete shielding of an electron accelerator facility.
Endo A; Harada Y; Kawasaki K; Kikuchi M
Appl Radiat Isot; 2004 Jun; 60(6):955-8. PubMed ID: 15110362
[TBL] [Abstract][Full Text] [Related]
40. Post-mortem considerations of Yttrium-90 90Y microsphere therapy procedures.
Nelson K; Vause PE; Koropova P
Health Phys; 2008 Nov; 95(5 Suppl):S156-61. PubMed ID: 18849708
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
